Total Pageviews

4/27/2013

Atticus Finch

So how many of you persons who are in favor of gun control are vegetarians? I believe that the most direct way to encourage peace in our society is to live what Ghandi called "non-violence" and Thich Nat Han calls "mindfulness." The easiest way for me to live each day mindfully and with non-violence is by abstaining from eating animals. I know that the consumption of animals harms the animals, other humans who are exploited in the industries, and the earth itself. Therefore I live most (90%) days on a vegetarian diet. (Sometimes I eat chicken or fish, but rarely. (I also help raise five chickens)). I am also a member of the NRA.








We're going to need those gun for dogs in post apocalyptic America...

1 comment:

  1. GSK in Europe for renal cell carcinoma therapy drugs Pazopanib

    GSK submitted its application in the development of oral anti-cancer drug Pazopanib to the European Food and Drug Administration, the drug can be approved for the treatment of advanced or metastatic renal cell carcinoma (RCC) patients.

    The application is based on the gratifying results in a phase III clinical trial. Pazopanib is a daily medication once angiogenesis inhibitors, mainly observed during the experiment, it is used not received any treatment or previously using cytokine therapy in patients with RCC how. The experimental primary clinical endpoint of progression free survival of the patient's condition, and secondary endpoints include overall survival, drug response rate and safety.

    Pazopanib in the United States listing application has been submitted in December last year. GSK R & D department official said, this is the fifth major new drug applications submitted since September 2008, which involved products including Genmab jointly developed Ofatumumab.


    Medchemexpress Can provide the above product,its website:www.medchemexpress.com



    GSK1904529A
    Linsitinib
    NVP-ADW742
    BMS-536924
    GSK1904529A
    NVP-AEW541
    Linsitinib
    Pazopanib
    Crenolanib
    Toceranib

    ReplyDelete